Metraipolis › archive › dc_dca5a2237ea3

LMP7 as a Target for Coronavirus Therapy: Inhibition by Ixazomib and Interaction with SARS-CoV-2 Proteins Nsp13 and Nsp16 — Europe PMC PMID:41011771

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41011771
DOI
10.3390/pathogens14090871
License (as archived)
solo-consultazione
Archived
2026-11-10T04:45:47.103Z
SHA-256 of the archived text
cfb05f46dad9c247e29d21d0466d5fdc0262fb1aec8cb21ec586e58e685004b8
Stable URL of this page
https://metraipolis.com/documento/dc_dca5a2237ea3

How to cite

LMP7 as a Target for Coronavirus Therapy: Inhibition by Ixazomib and Interaction with SARS-CoV-2 Proteins Nsp13 and Nsp16 — Europe PMC PMID:41011771 — Europe PMC (en), https://europepmc.org/article/MED/41011771 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dca5a2237ea3 (Metraipolis archive dc_dca5a2237ea3, sha256 cfb05f46dad9c247e29d21d0466d5fdc0262fb1aec8cb21ec586e58e685004b8)
BibTeX
@misc{dcdca5a2237ea3,
  title = {LMP7 as a Target for Coronavirus Therapy: Inhibition by Ixazomib and Interaction with SARS-CoV-2 Proteins Nsp13 and Nsp16 — Europe PMC PMID:41011771},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41011771},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dca5a2237ea3; sha256 cfb05f46dad9c247e29d21d0466d5fdc0262fb1aec8cb21ec586e58e685004b8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41011771. Agents can read the archived copy with the MCP tool read_document.